NPPA Caps Trade Margins on 137 Anti-Cancer Drugs Following Supreme Court Scrutiny

The Supreme Court highlighted a massive price gap where a cancer medicine costing ₹2,700 to supply is retailed at an MRP of ₹27,000.

Following the court's query, the National Pharmaceutical Pricing Authority announced a 30% cap on trade margins for 137 anti-cancer drugs.

The pricing intervention is scheduled to become effective starting November 9 to reduce high out-of-pocket costs for patients.